Carlos Villa Joins Versiti Blood Research Institute
Versiti Blood Research Institute shared on LinkedIn:
”Please welcome Carlos Villa, MD, PhD to VBRI!
Carlos Villa is joining the Translational Hematology Program as a Transfusion Medicine Clinician Investigator.
He joins Versiti from the US Food and Drug Administration where, most recently, he was the Associate Director for Special Programs in the Office of Blood Research and Review at CBER.
In that role, he contributed to regulatory, policy, and research initiatives to advance the safety and effectiveness of blood and blood components.
His clinical background is in Clinical Pathology and Transfusion Medicine, and his research has spanned basic sciences to clinical medicine, with experience in pharmacology and drug delivery.
He completed his MD/PhD training at the Tri Institutional program at Weill Cornell and Memorial Sloan Kettering, which was followed by residency and fellowship training at the University of Pennsylvania.”
Stay updated with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team